Increased sensitivity using real-time dPCR for detection of SARS-CoV-2

Biotechniques. 2021 Jan;70(1):7-20. doi: 10.2144/btn-2020-0133. Epub 2020 Nov 23.

Abstract

A real-time dPCR system was developed to improve the sensitivity, specificity and quantification accuracy of end point dPCR. We compared three technologies - real-time qPCR, end point dPCR and real-time dPCR - in the context of SARS-CoV-2. Some improvement in limit of detection was obtained with end point dPCR compared with real-time qPCR, and the limit of detection was further improved with the newly developed real-time dPCR technology through removal of false-positive signals. Real-time dPCR showed increased linear dynamic range compared with end point dPCR based on quantitation from amplification curves. Real-time dPCR can improve the performance of TaqMan assays beyond real-time qPCR and end point dPCR with better sensitivity and specificity, absolute quantification and a wider linear range of detection.

Keywords: SARS-CoV-2; dPCR; gene expression; infectious disease diagnostics; qPCR; real-time PCR; real-time digital PCR.

Publication types

  • Comparative Study

MeSH terms

  • COVID-19 / diagnosis
  • COVID-19 Nucleic Acid Testing / methods*
  • COVID-19 Nucleic Acid Testing / statistics & numerical data
  • Endpoint Determination
  • Humans
  • Real-Time Polymerase Chain Reaction*
  • SARS-CoV-2 / isolation & purification*